Level Four Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.99M Sell
51,008
-2,929
-5% -$236K 0.11% 204
2026
Q1
$4.67M Buy
53,937
+9,638
+22% +$923K 0.15% 181
2025
Q4
$4.26M Buy
44,299
+437
+1% +$42.4K 0.14% 189
2025
Q3
$4.18M Buy
43,862
+1,336
+3% +$123K 0.14% 193
2025
Q2
$3.71M Buy
42,526
+1,074
+3% +$91.1K 0.14% 195
2025
Q1
$3.72M Buy
41,452
+470
+1% +$42.1K 0.15% 180
2024
Q4
$3.27M Buy
40,982
+325
+0.8% +$28.1K 0.13% 182
2024
Q3
$3.63M Sell
40,657
-57,367
-59% -$4.83M 0.15% 175
2024
Q2
$7.72M Buy
98,024
+39,869
+69% +$3.27M 0.35% 56
2024
Q1
$4.79M Buy
58,155
+1,043
+2% +$89K 0.26% 100
2023
Q4
$4.7M Sell
57,112
-2,478
-4% -$189K 0.26% 98
2023
Q3
$4.67M Buy
59,590
+9,774
+20% +$818K 0.3% 80
2023
Q2
$4.39M Buy
49,816
+5,857
+13% +$504K 0.26% 89
2023
Q1
$3.54M Buy
43,959
+7,198
+20% +$587K 0.23% 110
2022
Q4
$2.86M Buy
36,761
+6,809
+23% +$552K 0.21% 118
2022
Q3
$2.42M Sell
29,952
-1,922
-6% -$173K 0.24% 112
2022
Q2
$2.86M Buy
31,874
+3,067
+11% +$311K 0.27% 105
2022
Q1
$3.2M Buy
28,807
+6,153
+27% +$650K 0.25% 107
2021
Q4
$2.34M Buy
22,654
+5,761
+34% +$667K 0.18% 139
2021
Q3
$2.12M Sell
16,893
-2,161
-11% -$280K 0.22% 119
2021
Q2
$2.37M Sell
19,054
-397
-2% -$49.8K 0.16% 145
2021
Q1
$2.3M Buy
19,451
+5
+0% +$586 0.18% 144
2020
Q4
$2.28M Sell
19,446
-792
-4% -$87.2K 0.18% 137
2020
Q3
$2.1M Sell
20,238
-23,372
-54% -$2.35M 0.16% 141
2020
Q2
$3.99M Buy
43,610
+23,484
+117% +$2.25M 0.31% 76
2020
Q1
$1.81M Buy
20,126
+475
+2% +$50.5K 0.22% 117
2019
Q4
$6.06M Buy
19,651
+2,363
+14% +$259K 0.24% 126
2019
Q3
$1.88M Sell
17,288
-592
-3% -$61.8K 0.19% 118
2019
Q2
$1.74M Buy
17,880
+704
+4% +$64.3K 0.18% 124
2019
Q1
$1.56M Sell
17,176
-3,275
-16% -$293K 0.17% 140
2018
Q4
$1.86M Sell
20,451
-916
-4% -$85.6K 0.23% 100
2018
Q3
$2.1M Sell
21,367
-597
-3% -$55.2K 0.23% 101
2018
Q2
$1.88M Buy
21,964
+6,046
+38% +$505K 0.14% 148
2018
Q1
$1.28M Buy
15,918
+2,335
+17% +$193K 0.1% 188
2017
Q4
$1.1M Buy
13,583
+865
+7% +$69.3K 0.09% 215
2017
Q3
$989K Sell
12,718
-25
-0.2% -$2.08K 0.09% 219
2017
Q2
$1.02M Sell
12,743
-4,602
-27% -$388K 0.16% 141
2017
Q1
$1.39M Sell
17,345
-3,412
-16% -$267K 0.14% 151
2016
Q4
$1.48M Buy
+20,757
New +$1.63M 0.19% 118

Other funds holding MDT

Level Four Advisory Services's MDT Position: Q2 2026 in Review

Level Four Advisory Services reduced its Medtronic (MDT) stake by 5.4% in Q2 2026, selling an estimated $236K and leaving 51,008 shares worth $3.99M. The position accounts for 0.11% of the portfolio, ranked #204.

Level Four Advisory Services first reported a position in MDT in Q4 2016 and has held it in 39 quarters since. The position peaked at $7.72M in Q2 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Level Four Advisory Services held 51,008 shares of Medtronic worth $3.99M as of Q2 2026.
  • Level Four Advisory Services sold 2,929 Medtronic shares in Q2 2026, an estimated $236K.
  • Medtronic made up 0.11% of Level Four Advisory Services's portfolio in Q2 2026, its #204 holding.
  • Level Four Advisory Services first reported a position in Medtronic in Q4 2016 and has held it in 39 quarters since.
  • Level Four Advisory Services's Medtronic position peaked at $7.72M in Q2 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.